We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Harte-Hanks
HHS
$16.9M
| $252K | ﹤0.01% |
3,506
-16,936
| -83% | -$1.31M |
|
902
Lifecore Biomedical
LFCR
$185M
| $246K | ﹤0.01% |
19,695
-2,983
| -13% | -$35.1K |
|
|
ADAM
903
Adamas Trust
ADAM
$886M
| $246K | ﹤0.01% |
+7,872
| New | +$243K |
|
904
Smith & Wesson
SWBI
$639M
| $243K | ﹤0.01% |
21,729
-294,958
| -93% | -$3.48M |
|
|
GRUB
905
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $242K | ﹤0.01% |
+3,415
| New | +$230K |
|
906
Neogen
NEOG
$2.48B
| $240K | ﹤0.01% |
+15,803
| New | +$235K |
|
|
EDR
907
DELISTED
Education Realty Trust Inc
EDR
| $239K | ﹤0.01% |
+7,406
| New | +$229K |
|
|
RLOC
908
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
| $239K | ﹤0.01% |
33,983
-45,345
| -57% | -$366K |
|
|
BBOX
909
DELISTED
Black Box Corp
BBOX
| $238K | ﹤0.01% |
+10,134
| New | +$231K |
|
910
Methode Electronics
MEI
$593M
| $237K | ﹤0.01% |
6,202
-8,652
| -58% | -$265K |
|
|
FSP
911
Franklin Street Properties
FSP
$45.9M
| $235K | ﹤0.01% |
18,660
-78
| -0.4% | -$969 |
|
912
First Community Bankshares
FCBC
$906M
| $230K | ﹤0.01% |
+16,031
| New | +$237K |
|
|
SRGA
913
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $226K | ﹤0.01% |
1,731
-1,058
| -38% | -$134K |
|
|
FPO
914
DELISTED
First Potomac Realty Trust
FPO
| $226K | ﹤0.01% |
+17,219
| New | +$224K |
|
|
PLKI
915
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
| $223K | ﹤0.01% |
5,097
-61,806
| -92% | -$2.52M |
|
|
KEM
916
DELISTED
KEMET Corporation
KEM
| $220K | ﹤0.01% |
38,289
+20,729
| +118% | +$115K |
|
917
iShares MSCI Indonesia ETF
EIDO
$500M
| $219K | ﹤0.01% |
+8,319
| New | +$231K |
|
918
Park Aerospace
PKE
$820M
| $206K | ﹤0.01% |
+7,310
| New | +$200K |
|
919
Haverty Furniture Companies
HVT
$452M
| $202K | ﹤0.01% |
8,043
-60,166
| -88% | -$1.53M |
|
920
ORIX
IX
$43.4B
| $201K | ﹤0.01% |
12,130
-5,025
| -29% | -$76.5K |
|
921
Spok Holdings
SPOK
$238M
| $193K | ﹤0.01% |
12,534
-3,322
| -21% | -$52.9K |
|
|
PTNR
922
DELISTED
Partner Communications
PTNR
| $190K | ﹤0.01% |
24,331
| – | – |
|
|
ZIXI
923
DELISTED
Zix Corporation
ZIXI
| $165K | ﹤0.01% |
48,158
-10,313
| -18% | -$36.2K |
|
924
Magnachip Semiconductor
MX
$145M
| $164K | ﹤0.01% |
11,627
-164,030
| -93% | -$2.21M |
|
|
FSYS
925
DELISTED
FUEL SYSTEMS SOLUTIONS INC COM STK
FSYS
| $164K | ﹤0.01% |
+14,750
| New | +$153K |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.